Literature DB >> 18931510

A likelihood model that accounts for censoring due to fetal loss can accurately test the effects of maternal and fetal genotype on the probability of miscarriage.

Colin I O'Donnell1, Charles J Glueck, Tasha E Fingerlin, Deborah H Glueck.   

Abstract

OBJECTIVE: Heritable maternal and fetal thrombophilia and/or hypofibrinolysis are important causes of miscarriage. Under the constraint that fetal genotype is observed only after a live birth, estimating risk is complicated. Censoring prevents use of published statistical methodology. We propose techniques to determine whether increases in miscarriage are due to the fetal genotype, maternal genotype, or both.
METHODS: We propose a study to estimate the risk of miscarriage contributed by an allele, expressed in either dominant or recessive fashion. Using a multinomial likelihood, we derive maximum likelihood estimates of risk for different genotype groups. We describe likelihood ratio tests and a planned hypothesis testing strategy.
RESULTS: Parameter estimation is accurate (bias <0.0011, root mean squared error <0.0780, n = 500). We used simulation to estimate power for studies of three gene mutations: the 4G hypofibrinolytic mutation in the plasminogen activator inhibitor gene (PAI-1), the prothrombin G20210A mutation, and the Factor V Leiden mutation. With 500 families, our methods have approximately 90% power to detect an increase in the miscarriage rate of 0.2, above a background rate of 0.2.
CONCLUSION: Our statistical method can determine whether increases in miscarriage are due to fetal genotype, maternal genotype, or both despite censoring. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931510      PMCID: PMC2755496          DOI: 10.1159/000164399

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  34 in total

1.  The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.

Authors:  Charles J Glueck; Joel Pranikoff; Dawit Aregawi; Mofiz Haque; Binghua Zhu; Trent Tracy; Ping Wang
Journal:  Metabolism       Date:  2005-10       Impact factor: 8.694

2.  Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads".

Authors:  A J Wilcox; C R Weinberg; R T Lie
Journal:  Am J Epidemiol       Date:  1998-11-01       Impact factor: 4.897

3.  Evaluating effects of exposures on embryo viability and uterine receptivity in in vitro fertilization.

Authors:  H Zhou; C R Weinberg
Journal:  Stat Med       Date:  1998-07-30       Impact factor: 2.373

4.  PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

Authors:  M Margaglione; G Cappucci; M d'Addedda; D Colaizzo; N Giuliani; G Vecchione; G Mascolo; E Grandone; G Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

5.  Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction.

Authors:  D S Dizon-Townson; L Meline; L M Nelson; M Varner; K Ward
Journal:  Am J Obstet Gynecol       Date:  1997-08       Impact factor: 8.661

6.  [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].

Authors:  Li-xue Guan; Xin-ying Du; Jing-xian Wang; Li Gao; Rui-li Wang; Hai-bo Li; Shou-xun Wang
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2005-06

7.  The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.

Authors:  V V Balasa; R A Gruppo; C J Glueck; D Stroop; A Becker; A Pillow; P Wang
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

8.  Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population.

Authors:  M Henry; N Chomiki; P Y Scarabin; M C Alessi; F Peiretti; D Arveiler; J Ferrières; A Evans; P Amouyel; O Poirier; F Cambien; I Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-05       Impact factor: 8.311

9.  Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

Authors:  P M Ridker; C H Hennekens; K Lindpaintner; M J Stampfer; J P Miletich
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

10.  Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study.

Authors:  E Nurk; G S Tell; H Refsum; P M Ueland; S E Vollset
Journal:  QJM       Date:  2006-04-13
View more
  1 in total

1.  Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Authors:  Stephan G Dixon; Carl T Bruce; Charles J Glueck; Robert A Sisk; Robert K Hutchins; Vybhav Jetty; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.